Cargando…

Optimizing β-Lactams against Tuberculosis

Detalles Bibliográficos
Autores principales:	de Jager, Veronique R., Vanker, Naadira, van der Merwe, Lize, van Brakel, Elana, Muliaditan, Morris, Diacon, Andreas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193855/ https://www.ncbi.nlm.nih.gov/pubmed/31922901 http://dx.doi.org/10.1164/rccm.201911-2149LE

Ejemplares similares

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Dooley, Kelly E., et al.
Publicado: (2020)

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
por: Diacon, Andreas H., et al.
Publicado: (2020)

Laboratory test result interpretation for primary care doctors in South Africa
por: Vanker, Naadira, et al.
Publicado: (2017)

Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg(−1) rifampicin
por: te Brake, Lindsey H.M., et al.
Publicado: (2021)

Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection
por: Rullas, Joaquín, et al.
Publicado: (2015)

In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Mycobacterium tuberculosis Clinical Isolates
por: Li, Fu, et al.
Publicado: (2018)

In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex
por: Economou Lundeberg, Elin, et al.
Publicado: (2023)

Obesity and its implications for COVID-19 pandemic in South Africa
por: van Vollenstee, Fiona A., et al.
Publicado: (2021)

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions
por: Gold, Ben, et al.
Publicado: (2022)

Pharmacodynamic optimization of β-lactams in the patient care setting
por: Nicolau, David P
Publicado: (2008)

Synthetic Lethality Reveals Mechanisms of Mycobacterium tuberculosis Resistance to β-Lactams
por: Lun, Shichun, et al.
Publicado: (2014)

120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01(E) Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection
por: Meeren, Olivier Van Der, et al.
Publicado: (2018)

Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations
por: Fröhlich, Christopher, et al.
Publicado: (2021)

“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials
por: Byrne, Anthony, et al.
Publicado: (2023)

In Patients with ARDS, Optimal PEEP Should Not Be Determined Using the Intersection of Relative Collapse and Relative Overdistention
por: van den Berg, Maarten, et al.
Publicado: (2020)

β-Lactam Antibiotics Renaissance
por: Qin, Wenling, et al.
Publicado: (2014)

β-Lactam Allergy in Children
por: Suleyman, Ayse, et al.
Publicado: (2021)

β-Lactams from the Ocean
por: Fisher, Jed F., et al.
Publicado: (2023)

1795. Safety Outcomes of the Use of β-Lactam Therapy in Patients With Documented β-Lactam Allergy
por: Bjork, Lauren
Publicado: (2018)

Diastereoselective Synthesis of Potent Antimalarial Cis-β-lactam Agents
por: Jarrahpour, Aliasghar, et al.
Publicado: (2019)

Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
por: Lindman, Marissa, et al.
Publicado: (2019)

Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics
por: Kim, Si Won, et al.
Publicado: (2018)

Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review
por: Haseeb, Abdul, et al.
Publicado: (2022)

In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors
por: Shields, Ryan K, et al.
Publicado: (2023)

The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas
por: Stangl, Anne L., et al.
Publicado: (2019)

Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals
por: Herzmann, Christian, et al.
Publicado: (2017)

Application of quantitative protein mass spectrometric data in the early predictive analysis of target engagement by monoclonal antibodies
por: Muliaditan, Morris, et al.
Publicado: (2022)

Screening of medicinal plants for antibacterial principles against β-lactam resistant strains
por: Vinod, N.V., et al.
Publicado: (2011)

Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii
por: Wang, Leilei, et al.
Publicado: (2021)

Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa
por: Dhiman, Shiv, et al.
Publicado: (2023)

Accuracy in diagnosis of allergy to β-lactams
por: Iglesias-Souto, Javier, et al.
Publicado: (2012)

Regulation and compartmentalization of β‐lactam biosynthesis
por: Martín, Juan F., et al.
Publicado: (2010)

Occupational allergy to β-lactam antibiotics
por: Classen, Anna, et al.
Publicado: (2015)

Hypersensitivity to non-β-lactam antibiotics
por: Merk, Hans F., et al.
Publicado: (2022)

Antipseudomonal β-Lactams Resistance in Iran
por: Rabiei, Mohammad Mahdi, et al.
Publicado: (2020)

Structural Insights for β-Lactam Antibiotics
por: Kim, Dogyeoung, et al.
Publicado: (2023)

Synthetic Approaches toward Monocyclic 3‐Amino‐β‐lactams
por: Deketelaere, Sari, et al.
Publicado: (2017)

Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
por: Park, Sanghee, et al.
Publicado: (2022)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
por: Luci, Giacomo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o10r9f6htk0mrkfpcef9ndp3tq